Učitavanje...
Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation
Post-transplantation cyclophosphamide (PTCy) reduces the incidences of severe acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). Yet, the standard clinical dose and timing of PTCy were partly extrapolated from MHC-matched skin allografting m...
Spremljeno u:
| Izdano u: | Biol Blood Marrow Transplant |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590501/ https://ncbi.nlm.nih.gov/pubmed/31586477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.030 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|